Stephens Inc. AR Sells 2,019 Shares of Sabra Healthcare REIT, Inc. $SBRA

Stephens Inc. AR cut its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.8% during the second quarter, Holdings Channel reports. The fund owned 40,473 shares of the real estate investment trust’s stock after selling 2,019 shares during the period. Stephens Inc. AR’s holdings in Sabra Healthcare REIT were worth $746,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of SBRA. Nuveen LLC bought a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $61,791,000. Jefferies Financial Group Inc. boosted its position in Sabra Healthcare REIT by 7,196.8% in the 1st quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust’s stock valued at $25,611,000 after buying an additional 1,445,909 shares during the last quarter. Swedbank AB bought a new position in Sabra Healthcare REIT in the 1st quarter valued at $19,336,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Sabra Healthcare REIT in the 2nd quarter valued at $7,048,000. Finally, Advisors Capital Management LLC boosted its position in Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock valued at $39,004,000 after buying an additional 380,505 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA opened at $18.08 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The stock’s 50-day simple moving average is $18.65 and its 200 day simple moving average is $18.22. The company has a market cap of $4.34 billion, a P/E ratio of 23.79, a P/E/G ratio of 1.16 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million during the quarter, compared to analysts’ expectations of $185.64 million. During the same quarter last year, the company posted $0.36 earnings per share. Sabra Healthcare REIT’s quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.6%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 157.89%.

Analysts Set New Price Targets

SBRA has been the topic of a number of recent research reports. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a research report on Tuesday. Finally, BMO Capital Markets boosted their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.75.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.